Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.06% Nasdaq Down 0.77%
Streaming
Ticker Tape: On

Theravance Inc. (THRX)

-NasdaqGS
27.01 Down 0.54(1.96%) 3:45PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Prev Close:27.55
Open:27.54
Bid:27.00 x 600
Ask:27.02 x 100
1y Target Est:42.00
Beta:0.68
Next Earnings Date: 6-May-14THRX Earnings announcement
Day's Range:26.76 - 27.96
52wk Range:26.04 - 42.96
Volume:881,231
Avg Vol (3m):997,324
Market Cap:3.02B
P/E (ttm):N/A
EPS (ttm):-1.67
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for THRX

Comparison

Symbol% ChgMkt Cap
THRXDown 1.96%3.02B
AZNUp 1.45%85.27B
CBSTDown 2.55%4.97B
PFEDown 0.19%197.49B

Key Statistics

Forward P/E (1 yr):87.10
P/S (ttm):648.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.22
Quarterly EPS Est (Mar-14) :-0.53
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Theravance, Inc., a biopharmaceutical company, is engaged in the discovery, development, and commercialization of small molecule medicines primarily for therapeutic areas of respiratory diseases, bacterial infections, and central nervous system/pain. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback